OR WAIT null SECS
April 06, 2022
Merck has expanded its manufacturing facility in Elkton, Va. to further increase its HPV vaccine supply.
April 05, 2022
UK government has awarded chemical producer Croda a £15.9 million grant to increase the UK’s capacity to manufacture key vaccine ingredients.
Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.
April 01, 2022
Rentschler Biopharma and Vetter are unveiling a strategic collaboration called Xpert Alliance.
Symbiosis announced the successful completion of UK Research and Innovation project to enhance the manufacturing supply chain for ATMPs within the UK.
Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.
March 31, 2022
KeyPlants has shipped a first-of-its-kind vaccine manufacturing facility to Senegal in West Africa.
March 25, 2022
DFE Pharma, Harro Höfliger, and Sterling have announced a partnership called Inhalation Together to provide formulation services for respiratory products.
March 24, 2022
Roquette is investing €25 million at its site in Lestrem, France to strengthen its position in the polyols market.
Recro Pharma changed its name to Societal CDMO to reflect the company’s expansion as a result of the acquisition of IriSys.